MoonLake Immunotherapeutics Class A Ordinary Shares

MLTX us
$12.04
▼ 0.08 (-0.66%)
Volume: 1,900,015 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 15
  • 21d momentum -22.9%
  • MA aligned bearish
  • RSI 30
🎯 Pullback 66
  • RSI 30 near lows
  • Near lower Bollinger band
  • -10.8% vs 20MA
💎 Value 58
  • -48% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)30.3
MACD+0.039
MA trendBearish
ATR6.14%
21d mom.-22.9%
63d mom.-39.5%
vs 20MA-10.8%
RVOL(20)1.19×
52w low · 6 52w high · 23
-48.3% from 52-week high
20d support 12 · resistance 16

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap$1.0B
PER—
PBR2.41
PSR—
EPS$-3.08
ROE-61.2%
ROA-45.7%
Dividend yield0.00%
Debt/Equity0.23
EV/EBITDA-2.46
week1M3M6M1YYTD
-2.82% -22.92% -39.50% -32.17% -77.68% +0.75%

Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
0/10
🐻 Bear
10/10

14d momentum -19.79%, daily vol 2.94%. MoonLake Immunotherapeutics Class A Ordinary Shares sits in a bearish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.